MAPT and systemic sclerosis: Lee et al. have shown that SSc can inhibit the secretion of Aβ1-40 and Aβ1-42 and the phosphorylation of tau and promote nerve growth factor-mediated axonal growth (Lee et al., 2016; Kim, 2018).